Last updated: February 18, 2024
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Overall Status: Active - Recruiting
Phase
N/A
Condition
Surgery
Treatment
Surgery
Clinical Study ID
NCT06277180
TCR-FAPI for MTC Surgery
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age between 18 and 75 years;
- Diagnosed with MTC and have surgical indication based on preliminary evaluation; thetumor may be newly diagnosed or previously treated;
- Expected survival of at least 12 weeks;
- No major organ dysfunction (heart, lung, liver, kidney and other major organ include),acute or life-threatening status of infection;
- Be willing and able to understand the research content and provide written informedconsent/assent for the trial.
Exclusion
Exclusion Criteria:
- Have a history of imaging agent allergies;
- Does not meet the PET-CT scan sedation requirements, or has contraindications forPET-CT examination;
- Be pregnant or breastfeeding, or expecting to conceive or father children within theprojected duration of the trial;
- No surgical indication (i.e., no measurable disease, unresectable disease, orsignificant present of distant metastasis), refusing surgery or 68Ga-TCR-FAPIPET/CT-guided surgery.
Study Design
Total Participants: 50
Treatment Group(s): 1
Primary Treatment: Surgery
Phase:
Study Start date:
October 01, 2023
Estimated Completion Date:
December 31, 2027
Study Description
Connect with a study center
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, 100021
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.